McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

McKesson Co. (NYSE:MCK – Get Free Report)’s share price reached a new 52-week high during trading on Friday . The company traded as high as $672.00 and last traded at $665.41, with a volume of 16398 ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including ...

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...

McKesson (MCK) closed the most recent trading day at $663.79, moving +0.33% from the previous trading session. The stock lagged the S&P 500's daily gain of 1.08%. Elsewhere, the Dow gained 0.92%, ...

Total revenue fell short of analysts' expectations. Adjusted EPS of $7.88 beat analyst estimates by 9%. The company raised its full-year EPS guidance. Source: Analyst estimates for the quarter ...

In that same time, the Medical sector lost 1.17%, while the S&P 500 lost 5.73%. The investment community will be paying close attention to the earnings performance of McKesson in its upcoming release.

With a market cap of $75.6 billion, McKesson delivers pharmaceuticals, medical supplies, and technology solutions that enhance healthcare efficiency and patient outcomes, supporting pharmacies ...

Connor Clark & Lunn Investment Management Ltd. grew its holdings in McKesson Co. (NYSE:MCK – Free Report) by 300.6% during ...

Just remind us sort of what the benefits we could see for McKesson as it relates to flu ... and good visit traffic in oncology. In the medical space, through the third quarter, so December ...

Founded in 1833 as drug importer and wholesaler, McKesson (NYSE:MCK) today is a distributor and services company that ...